KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Times Interest Earned (2016 - 2025)

West Pharmaceutical Services' Times Interest Earned history spans 17 years, with the latest figure at -$783.0 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 292.48% year-over-year to -$783.0; the TTM value through Dec 2025 reached $1169.8, up 515.79%, while the annual FY2025 figure was $1169.8, 515.79% up from the prior year.
  • Times Interest Earned for Q4 2025 was -$783.0 at West Pharmaceutical Services, down from $838.0 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $1537.0 in Q2 2025 and bottomed at -$783.0 in Q4 2025.
  • The 5-year median for Times Interest Earned is $85.43 (2022), against an average of $156.7.
  • The largest YoY upside for Times Interest Earned was 1726.86% in 2025 against a maximum downside of 292.48% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at $70.77 in 2021, then increased by 7.81% to $76.29 in 2022, then soared by 75.75% to $134.08 in 2023, then tumbled by 248.79% to -$199.5 in 2024, then plummeted by 292.48% to -$783.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Times Interest Earned are -$783.0 (Q4 2025), $838.0 (Q3 2025), and $1537.0 (Q2 2025).